An Open Label, Phase 1b, Ascending Dose Study of DM199

Completed

Phase 1 Results N/A

Summary of Purpose

This is a Phase 1B study to assess the safety, tolerability and pharmacokinetics of DM199 in healthy volunteers. The study will be consist of two parts: Part A will focus on intravenous dosing and Part B will directly compare intravenous dosing with subcutaneous dosing.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 25 April 2017.

1 Sep 2016 8 Aug 2016 1 Mar 2017 1 Mar 2017 1 Apr 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Parallel Assignment

Contacts